"Anthropic has committed $200 million over four years to a partnership with the Bill & Melinda Gates Foundation, the largest deal of its kind between an AI company and a global philanthropy. The money, a mix of grant funding, Claude usage credits, and technical support, will fund programmes in global health, life sciences, education, and economic mobility, with partners in the United States and developing countries. Anthropic's contribution takes the form of engineering staff time and API credits; the Gates Foundation provides grant funding, programme design, and field expertise."
"The partnership will use Claude to accelerate vaccine research for neglected diseases, build literacy tools for sub-Saharan Africa and India, and release public benchmarks and datasets. The largest share of the $200 million will go toward improving health outcomes in low- and middle-income countries, where roughly 4.6 billion people lack access to essential health services, according to the World Health Organisation. The programmes span three broad areas: accelerating drug and vaccine development, helping governments use health data, and supporting delivery of care."
"The partnership is the most substantial indication yet that Anthropic, which is approaching a $900 billion valuation, intends to build a meaningful non-commercial operation alongside its enterprise business. The company's Beneficial Deployments team, which leads the work, already offers nonprofits and educational institutions discounted access to Claude. But the Gates Foundation deal represents a step change in scale: it dwarfs the $50 million partnership that OpenAI struck with the same foundation at Davos in January to deploy AI in African healthcare clinics."
Anthropic and the Bill & Melinda Gates Foundation will commit $200 million over four years to fund AI programmes across global health, life sciences, education, and economic mobility. Funding will include grant support, Claude usage credits, and technical assistance, with partners in the United States and developing countries. The work will use Claude to accelerate vaccine research for neglected diseases, support drug and vaccine development, and help governments use health data and AI tools. Education efforts will build literacy tools for sub-Saharan Africa and India. Economic mobility initiatives will focus on improving access to opportunities. The partnership will also release public benchmarks and datasets to support broader research and evaluation.
#ai-in-global-health #vaccine-and-drug-development #education-and-literacy-tools #economic-mobility #philanthropy-and-public-datasets
Read at TNW | Anthropic
Unable to calculate read time
Collection
[
|
...
]